Glucotrack Inc (GCTK) Stock Price, Quote & News

Company Profile

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack, a non-invasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain through a small sensor clipped onto the earlobe. It is also developing the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 201 842 7715

Website: glucotrack.com

Address:

301 Route 17 North, Suite 800, Rutherford, United States

MarioMon Jun. 16 at 8:55 PM

$GCTK Lets get back to under 1

0 · Reply

TwongStocks Jun. 16 at 8:42 PM

Today's RS results, part 2 $GCTK 1 for 60 Previous close $0.0949, $5.694 split-adjusted Today's close $6.305 🟢Up 10.73% $NCI 1 for 5 Previous close $0.3406, $1.703 split-adjusted Today's close $1.89 🟢Up 10.98% $CBIO (formerly $GLYC) 1 for 100 Previous close $0.157, $15.70 split-adjusted Today's close $15.795 🟢Up 0.61%

0 · Reply

makedatbread88 Jun. 16 at 7:57 PM

$GCTK $JFBR $VLCN starting to run keep an eye these move fast!

0 · Reply

6ixBull Jun. 16 at 7:34 PM

$GCTK tomorrow will be a heater

0 · Reply

topstockalerts Jun. 16 at 7:21 PM

$GCTK keep it on your radar for tomorrow..🏦📈🍾

0 · Reply

Phil1049 Jun. 16 at 6:53 PM

$GCTK whatever 🙄

0 · Reply

makedatbread88 Jun. 16 at 6:44 PM

$GCTK $JFBR $VLCN all have 500k floats now after their reverse splits Which one doubles first? Let's see!

1 · Reply

6ixBull Jun. 16 at 6:33 PM

$GCTK she wants to run

0 · Reply

Brokechump Jun. 16 at 6:32 PM

$GCTK How many short shares after the split?

0 · Reply

makedatbread88 Jun. 16 at 6:01 PM

$GCTK volume tells all today Someone’s trying to “lock the float” Only 500k float with any news this goes $20+ in seconds

2 · Reply

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

Jun 4, 2025, 8:30 AM EDT - 12 days ago

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

May 28, 2025, 8:30 AM EDT - 19 days ago

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

May 20, 2025, 8:30 AM EDT - 27 days ago

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development

May 14, 2025, 5:10 PM EDT - 4 weeks ago

Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 13, 2025, 8:01 AM EDT - 4 weeks ago

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor

Apr 16, 2025, 8:00 AM EDT - 2 months ago

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas

Apr 3, 2025, 8:01 AM EDT - 2 months ago

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor

Mar 31, 2025, 5:00 PM EDT - 2 months ago

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights

Mar 19, 2025, 8:01 AM EDT - 3 months ago

Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes

Feb 26, 2025, 8:01 AM EST - 3 months ago

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

Feb 4, 2025, 12:24 PM EST - 4 months ago

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

Feb 4, 2025, 8:01 AM EST - 4 months ago

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

Jan 29, 2025, 9:00 AM EST - 4 months ago

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer

Jan 21, 2025, 8:01 AM EST - 5 months ago

Glucotrack Announces ISO 13485:2016 Certification

Jan 15, 2025, 8:01 AM EST - 5 months ago

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs

Jan 7, 2025, 4:05 PM EST - 5 months ago

Glucotrack to Present at TechBio Showcase™ 2025

Dec 3, 2024, 8:30 AM EST - 6 months ago

GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR

Nov 14, 2024, 4:30 PM EST - 7 months ago

Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt

Oct 22, 2024, 9:00 AM EDT - 8 months ago

GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE

Oct 1, 2024, 9:00 AM EDT - 9 months ago

GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING

Sep 3, 2024, 9:00 AM EDT - 10 months ago

JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS

Aug 15, 2024, 9:00 AM EDT - 10 months ago

Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference

Aug 5, 2024, 9:00 AM EDT - 11 months ago

GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE

Jun 20, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS

Jun 13, 2024, 9:19 AM EDT - 1 year ago

GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR

Jun 10, 2024, 10:50 AM EDT - 1 year ago

GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE

Jun 5, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

May 16, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY

May 15, 2024, 4:15 PM EDT - 1 year ago

GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT

May 2, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION

Apr 22, 2024, 2:10 PM EDT - 1 year ago

GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT

Apr 16, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING

Apr 2, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Mar 12, 2024, 9:30 AM EDT - 1 year ago

GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY

Feb 27, 2024, 8:30 AM EST - 1 year ago

GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Feb 13, 2024, 9:30 AM EST - 1 year ago

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAVÉ TO CHAIR OF THE BOARD OF DIRECTORS

Jan 2, 2024, 12:33 PM EST - 1 year ago

GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

Nov 30, 2023, 5:39 PM EST - 1 year ago

GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

Nov 13, 2023, 9:00 AM EST - 1 year ago

GLUCOTRACK ANNOUNCES SHAREHOLDER UPDATE

Oct 12, 2023, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES PRECLINICAL TESTING WITH IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

Aug 31, 2023, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ERIN CARTER TO BOARD OF DIRECTORS

Aug 28, 2023, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES NEW VP OF MARKETING

Jul 25, 2023, 9:00 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES POSITIVE DATA FROM FEASIBILITY STUDY FOR IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

Apr 17, 2023, 11:05 AM EDT - 2 years ago

Aegis Capital Corp. Acted as Sole Bookrunner on a $10 Million Underwritten Public Offering for GlucoTrack, Inc. (NASDAQ: GCTK)

Apr 17, 2023, 9:15 AM EDT - 2 years ago

GlucoTrack Closes $10 Million Underwritten Public Offering of Common Stock

Apr 13, 2023, 9:22 AM EDT - 2 years ago

GlucoTrack Announces Pricing of $10 Million Underwritten Public Offering of Common Stock

Apr 12, 2023, 5:50 PM EDT - 2 years ago

GlucoTrack Announces Proposed Underwritten Public Offering of Common Stock

Mar 14, 2023, 10:00 AM EDT - 2 years ago

GLUCOTRACK PROVIDES SHAREHOLDER UPDATE

Oct 14, 2022, 9:45 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES THE HIRING OF DR. MARK TAPSAK

MarioMon Jun. 16 at 8:55 PM

$GCTK Lets get back to under 1

0 · Reply

TwongStocks Jun. 16 at 8:42 PM

0 · Reply

makedatbread88 Jun. 16 at 7:57 PM

$GCTK $JFBR $VLCN starting to run keep an eye these move fast!

0 · Reply

6ixBull Jun. 16 at 7:34 PM

$GCTK tomorrow will be a heater

0 · Reply

topstockalerts Jun. 16 at 7:21 PM

$GCTK keep it on your radar for tomorrow..🏦📈🍾

0 · Reply

Phil1049 Jun. 16 at 6:53 PM

$GCTK whatever 🙄

0 · Reply

makedatbread88 Jun. 16 at 6:44 PM

$GCTK $JFBR $VLCN all have 500k floats now after their reverse splits Which one doubles first? Let's see!

1 · Reply

6ixBull Jun. 16 at 6:33 PM

$GCTK she wants to run

0 · Reply

Brokechump Jun. 16 at 6:32 PM

$GCTK How many short shares after the split?

0 · Reply

makedatbread88 Jun. 16 at 6:01 PM

$GCTK volume tells all today Someone’s trying to “lock the float” Only 500k float with any news this goes $20+ in seconds

2 · Reply

topstockalerts Jun. 16 at 5:51 PM

$GCTK keep an eye for today..🚨🚨🚨

0 · Reply

stocker_lol Jun. 16 at 5:40 PM

$GCTK $MULN lo this mf

0 · Reply

Hedgieguy75 Jun. 16 at 5:39 PM

$GCTK oh it's coming $6.80 clear and insta gap fill to $8 but you do you $MULN degens take a 👀

0 · Reply

Rilestrading88 Jun. 16 at 5:36 PM

$GCTK this stock now has to run up to $30 for me to break even. 😎

0 · Reply

Ace5th Jun. 16 at 5:23 PM

$GCTK perfect price to take out a short position here

0 · Reply

Nadz1 Jun. 16 at 5:20 PM

$GCTK nice and steady incline sends it! 🚀 👩‍🚀 🌙

0 · Reply

BeerRunner Jun. 16 at 4:53 PM

$GCTK So, still trading around a dime a share (pre manipulation). BFD.

0 · Reply

The_Sophisticate Jun. 16 at 4:31 PM

$GCTK

0 · Reply

topstockalerts Jun. 16 at 4:20 PM

$GCTK setting up nicely..🚨🚨..

0 · Reply

Sauceg Jun. 16 at 3:57 PM

$GCTK another noob on board lol

0 · Reply

Sauceg Jun. 16 at 3:56 PM

$GCTK cooked penny scam called this way before last RS This stock is done

0 · Reply

MarioMon Jun. 16 at 3:34 PM

$GCTK Remember they havent even made a device for the masses. All they did is change the wording

0 · Reply

Market Cap	2.72M
Revenue (ttm)	0.00
Net Income (ttm)	-22.60M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.03

Volume	169,275
Avg Vol	4,927,742
Day's Range	N/A - N/A
Shares Out	28.64M
Stochastic %K	3%
Beta	-0.19
Analysts	Strong Buy
Price Target	N/A